Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Crinetics Pharmaceuticals' Liabilities and Shareholders Equity came in at $1.32 billion for Q2 2026, up 2.5% from $1.29 billion a year earlier but down 5.7% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Crinetics Pharmaceuticals' Liabilities and Shareholders Equity was $1.13 billion, down 21.5% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 43.8% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $1.43 billion in FY2024 (+125.8%), $635.35 million in FY2023 (+80.4%), $352.18 million in FY2022 (+0.3%) and $351.02 million in FY2021 (+91.3%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $209.36 million (Q3 2021) to $1.43 billion (Q4 2024).
  • Year-over-year, Liabilities and Shareholders Equity increased in seven of the last eight quarters, with growth averaging 32.6%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2024 (growth of 219.0%), and the weakest in Q2 2023 (a decline of 30.5%).
  • Business Quant data shows CRNX's Liabilities and Shareholders Equity at $1.4 billion (Q1 2026), $1.13 billion (Q4 2025) and $1.2 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 1.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.32 Bn
Mar 31, 2026 1.40 Bn
Dec 31, 2025 1.13 Bn
Sep 30, 2025 1.20 Bn
Jun 30, 2025 1.29 Bn
Mar 31, 2025 1.36 Bn
Dec 31, 2024 1.43 Bn
Sep 30, 2024 937.37 Mn
Jun 30, 2024 935.54 Mn
Mar 31, 2024 978.15 Mn
Dec 31, 2023 635.35 Mn
Sep 30, 2023 641.54 Mn
Jun 30, 2023 293.25 Mn
Mar 31, 2023 314.01 Mn
Dec 31, 2022 352.18 Mn
Sep 30, 2022 384.88 Mn
Jun 30, 2022 421.73 Mn
Mar 31, 2022 333.29 Mn
Dec 31, 2021 351.02 Mn
Sep 30, 2021 209.36 Mn
API Access

Crinetics Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRNX&period=max&api_key=YOUR_API_KEY